About this trial
The purpose of this study is to test whether a special memory training program, called CogMed, can help people with early memory problems. The Investigators want to see if this training improves memory and also helps reduce stress.
The Investigators also want to see if CogMed results in changes to a blood biomarker called p-Tau 217, which possibly indicate Alzheimer's disease (AD).
Eligibility criteria
Qualifiers
Male or female outpatients ages ≥ 50 years;
Meet Mayo Clinic Criteria for MCI. (Patients with mild cognitive impairment)
Access to the internet through computer
A proficiency in speaking and reading English or having a family member who is proficient in reading and speaking English and is willing to serve as a translator.
Disqualifiers
Mini Mental State Exam (MMSE) score less than 19 or patients diagnosed with moderate or severe dementia by a clinician.
In the opinion of the investigator, participation would not be in the best interest of the subject.
Trial design
Treatments tested in this trial
- CogMed
Treatment groups
Sponsors and collaborators
St. Joseph's Hospital and Medical Center, Phoenix
Lead sponsor
Barrow Neurological Foundation
Collaborator
Barrow Neurological Institute
Collaborator